Bladder surface glycosaminoglycans: an epithelial permeability barrier L Parsons, D Boychuk, S Jones, R Hurst, H Callahan The Journal of urology 143 (1), 139-142, 1990 | 442 | 1990 |
A comparison of multiple urine markers for interstitial cystitis DR Erickson, SX Xie, VP Bhavanandan, MA Wheeler, RE Hurst, ... The Journal of urology 167 (6), 2461-2469, 2002 | 225 | 2002 |
Structure, function, and pathology of proteoglycans and glycosaminoglycans in the urinary tract RE Hurst World journal of urology 12 (1), 3-10, 1994 | 202 | 1994 |
Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis G Slobodov, M Feloney, C Gran, KD Kyker, RE Hurst, DJ Culkin The Journal of urology 171 (4), 1554-1558, 2004 | 199 | 2004 |
Analysis of sulfate in complex carbohydrates LJ Silvestri, RE Hurst, L Simpson, JM Settine Analytical Biochemistry 123 (2), 303-309, 1982 | 167 | 1982 |
A deficit of chondroitin sulfate proteoglycans on the bladder uroepithelium in interstitial cystitis RE Hurst, JB Roy, KW Min, RW Veltri, G Marley, K Patton, DL Shackelford, ... Urology 48 (5), 817-821, 1996 | 160 | 1996 |
Functional and structural characteristics of the glycosaminoglycans of the bladder luminal surface RE Hurst, SW Rhodes, PB Adamson, CL Parsons, JB Roy The Journal of urology 138 (2), 433-437, 1987 | 152 | 1987 |
Abnormal expression of differentiation related proteins and proteoglycan core proteins in the urothelium of patients with interstitial cystitis PJ Hauser, MG Dozmorov, BL Bane, G Slobodov, DJ Culkin, RE Hurst The Journal of urology 179 (2), 764-769, 2008 | 129 | 2008 |
Cell analysis method using quantitative fluorescence image analysis GP Hemstreet III, RE Hurst, RB Bonner, JY Rao US Patent 5,733,721, 1998 | 129 | 1998 |
Unique patterns of molecular profiling between human prostate cancer LNCaP and PC‐3 cells MG Dozmorov, RE Hurst, DJ Culkin, BP Kropp, MB Frank, J Osban, ... The Prostate 69 (10), 1077-1090, 2009 | 121 | 2009 |
Alterations in phenotypic biochemical markers in bladder epithelium during tumorigenesis. JY Rao, GP Hemstreet 3rd, RE Hurst, RB Bonner, PL Jones, KW Min, ... Proceedings of the National Academy of Sciences 90 (17), 8287-8291, 1993 | 118 | 1993 |
Bladder defense molecules, urothelial differentiation, urinary biomarkers, and interstitial cystitis RE Hurst, RM Moldwin, SG Mulholland Urology 69 (4), S17-S23, 2007 | 114 | 2007 |
Cellular F-actin levels as a marker for cellular transformation: relationship to cell division and differentiation JY Rao, RE Hurst, WD Bales, PL Jones, RA Bass, LT Archer, PB Bell, ... Cancer Research 50 (8), 2215-2220, 1990 | 113 | 1990 |
Curcumin: a new radio-sensitizer of squamous cell carcinoma cells AVI Khafif, R Hurst, K Kyker, DM Fliss, ZIV Gil, JE Medina Otolaryngology—Head and Neck Surgery 132 (2), 317-321, 2005 | 111 | 2005 |
Mapping of the distribution of significant proteins and proteoglycans in small intestinal submucosa by fluorescence microscopy RE Hurst, RB Bonner Journal of Biomaterials Science, Polymer Edition 12 (11), 1267-1279, 2001 | 105 | 2001 |
Biomarker risk assessment and bladder cancer detection in a cohort exposed to benzidine GP Hemstreet III, S Yin, Z Ma, RB Bonner, W Bi, JY Rao, M Zang, Q Zheng, ... Journal of the National Cancer Institute 93 (6), 427-436, 2001 | 102 | 2001 |
Identification of proteoglycans present at high density on bovine and human bladder luminal surface RE Hurst, R Zebrowski The Journal of urology 152 (5), 1641-1645, 1994 | 96 | 1994 |
Development and characterization of a preclinical model of breast cancer lung micrometastatic to macrometastatic progression LC Bailey-Downs, JE Thorpe, BC Disch, A Bastian, PJ Hauser, T Farasyn, ... PloS one 9 (5), e98624, 2014 | 94 | 2014 |
Structure-activity relationships of heparin. Independence of heparin charge density and antithrombin-binding domains in thrombin inhibition by antithrombin and heparin cofactor II. RE Hurst, MC Poon, MJ Griffith The Journal of clinical investigation 72 (3), 1042-1045, 1983 | 88 | 1983 |
Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progressioan MG Dozmorov, JT Azzarello, JD Wren, KM Fung, Q Yang, JS Davis, ... BMC cancer 10, 1-16, 2010 | 87 | 2010 |